Shubhra Mishra

Shubhra Mishra

Auto-generated profile, based on publicly available information

Shubhra Mishra

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2020 in Hepatology International
Verified
Journal Article
Closed access
PDF file
PKPraveen Kumar-M
Praveen Kumar-M
SMShubhra Mishra
Shubhra Mishra
DJDaya Krishna Jha
Daya Krishna Jha
JSJayendra Shukla
Jayendra Shukla
ACArup Choudhury
Arup Choudhury
VSVishal Sharma
Vishal Sharma

20 September 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
VSVishal Sharma
Vishal Sharma
HSHariom Soni
Hariom Soni
PKPraveen Kumar-M
Praveen Kumar-M
SDSaurabh Dawra
Saurabh Dawra
SMShubhra Mishra
Shubhra Mishra
UDUsha K. Dutta
Usha K. Dutta
We performed a meta-analysis to determine diagnostic accuracy of Xpert MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various tissues (intestinal, omental/perito...

14 May 2021 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
AJAnuraag Jena
Anuraag Jena
SMShubhra Mishra
Shubhra Mishra
ASAnurag Sachan
Anurag Sachan
HSHarjeet Singh
Harjeet Singh
ASAnupam Kumar Singh
Anupam Kumar Singh
VSVishal Sharma
Vishal Sharma

15 March 2021 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
AJAnuraag Jena
Anuraag Jena
DJDaya Krishna Jha
Daya Krishna Jha
PKPraveen Kumar-M
Praveen Kumar-M
KKKripa Shanker Kasudhan
Kripa Shanker Kasudhan
AKAnkit Kumar
Ankit Kumar
VSVishal Sharma
Vishal Sharma
Background: Prevalence and impact of thiopurine S-methyltransferase (TPMT) and Nudix hydrolase (NUDT15) minor allele frequencies in South Asian population is unclear. Methods: We searched PubMed and Embase with keywords-TPMT and NUDT15 combined with South Asian countries. We included studies reporting frequency of TPMT and NUDT15 polymorphisms. We estimated the pooled prevalence of TPMT and NUDT15 polymorphisms and their impact on pooled odds ratio of adverse events with thiopurines. Results: We included 26 studies in our analysis. The pooled prevalence of NUDT15 and TPMT polymorphisms was 16.5% (95% CI: 13.09–20.58) and 4.57% (95% CI: 3.66–5.68), respectively. In patients with adverse effects, the pooled prevalence of NUDT15 and TPMT polymorphism was 49.51% (95% C.I. 21.69–77.64) and 9.47% (95% C.I. 5.39–16.11), respectively. The odds ratio (OR) of adverse events with presence of TPMT polymorphisms was 3.65 (95% C.I., 1.43–9.28). The pooled OR for adverse events in presence of NUDT15 polymorphism was 12.63 (95% C.I., 3.68–43.26). Conclusion: NUDT15 were reported more frequently than the TPMT polymorphisms in South Asian population and were more frequently associated with adverse events. These findings may have implications for preemptive testing amongst South Asian population and immigrants prior to starting thiopurines.

14 December 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
SMShubhra Mishra
Shubhra Mishra
HMHarshal S Mandavdhare
Harshal S Mandavdhare
HSHarjeet Singh
Harjeet Singh
ACArup Choudhury
Arup Choudhury
JSJimil Shah
Jimil Shah
VSVishal Sharma
Vishal Sharma
To evaluate the use of a combination of antibiotics as an adjuvant therapy in acute severe ulcerative colitis (ASUC). Patients with ASUC were randomized to either infusions of placebo or intravenou...

2 August 2022 in Expert Review of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
SMShubhra Mishra
Shubhra Mishra
AJAnuraag Jena
Anuraag Jena
RKRinkalben Kakadiya
Rinkalben Kakadiya
VSVishal Sharma
Vishal Sharma
VAVineet Ahuja
Vineet Ahuja
Tofacitinib has emerged as a useful drug for the treatment of ulcerative colitis (UC).There is an unmet need for cost-effective, non-immunogenic drugs with a safe adverse effect profile to treat pa...